Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry v3.7.0 appears in the history, replacing the previous v3.6.6. This indicates an update to the page's revision-tracking mechanism rather than changes to the study details.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded revision v3.6.6 to the study's record history, reflecting an update to the page's versioning. The previous revision v3.6.5 is no longer listed in the current history.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision label 'Revision: v3.6.5' appears in the history, while the previous 'Revision: v3.6.4' entry is removed, reflecting a backend update to the page's version history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study record history adds a new revision entry for version v3.6.4, replacing v3.6.3 and indicating an updated record version.SummaryDifference0.1%

- Check101 days agoChange DetectedThe latest history entry is updated to Revision: v3.6.3, replacing the previous v3.6.2. This is an administrative update to the history list and does not modify study data or user-facing content.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.